The Effects of Ethanol on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Retigabine

Trial Profile

The Effects of Ethanol on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Retigabine

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jan 2013

At a glance

  • Drugs Retigabine (Primary)
  • Indications Epilepsy; Partial epilepsies
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Valeant Pharmaceuticals International
  • Most Recent Events

    • 16 Apr 2011 Results presented at the 63rd Annual Meeting of the American Academy of Neurology.
    • 14 Apr 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top